Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W
Mol Cancer. 2025; 24(1):66.
PMID: 40038722
PMC: 11881328.
DOI: 10.1186/s12943-025-02255-4.
Brisse M, Hickman H
Microorganisms. 2025; 13(2).
PMID: 40005808
PMC: 11858409.
DOI: 10.3390/microorganisms13020443.
Naqvi R, Valverde A, Shukla D, Naqvi A
Genes Immun. 2025; .
PMID: 40000873
DOI: 10.1038/s41435-025-00323-9.
Zhang Z, Zhao L, Huang T, Chen Z, Zhao Y, Liang J
Front Immunol. 2025; 15:1531294.
PMID: 39906740
PMC: 11792090.
DOI: 10.3389/fimmu.2024.1531294.
Li Z, Lin X, Yang Y, Tian M, Zhang L, Huang F
Sci Rep. 2025; 15(1):4002.
PMID: 39893221
PMC: 11787328.
DOI: 10.1038/s41598-025-88126-w.
Induces Two Types of Dendritic Cell Activation and Effectively Suppresses Onset of the Common Cold: A Randomized, Double-Blind, Placebo-Controlled Trial.
Wada H, Mawatari T, Saito Y, Azuma N, Iwama Y
Nutrients. 2025; 17(1.
PMID: 39796535
PMC: 11723090.
DOI: 10.3390/nu17010101.
Polyfunctional T cells and unique cytokine clusters imprint the anti rAAV2/rAAV9 vector immune response.
Holtkamp S, Lagoda F, Lister A, Harish P, Kleymann U, Pesch T
Front Immunol. 2024; 15:1450524.
PMID: 39654900
PMC: 11625739.
DOI: 10.3389/fimmu.2024.1450524.
Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy.
Liu H, Lu Y, Zong J, Zhang B, Li X, Qi H
J Nanobiotechnology. 2024; 22(1):663.
PMID: 39465376
PMC: 11520105.
DOI: 10.1186/s12951-024-02913-7.
The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy.
Ribeiro A, Neuper T, Horejs-Hoeck J
Int J Nanomedicine. 2024; 19:10685-10697.
PMID: 39464674
PMC: 11512692.
DOI: 10.2147/IJN.S477320.
Extracellular Silica Nanomatrices Promote In Vitro Maturation of Anti-tumor Dendritic Cells via Activation of Focal Adhesion Kinase.
Tam S, Cheung A, Qin P, Zhang S, Huang Z, Yung K
Adv Mater. 2024; 37(2):e2314358.
PMID: 39268785
PMC: 11733713.
DOI: 10.1002/adma.202314358.
Innate Immune Cells in Melanoma: Implications for Immunotherapy.
Trocchia M, Ventrici A, Modestino L, Cristinziano L, Ferrara A, Palestra F
Int J Mol Sci. 2024; 25(15).
PMID: 39126091
PMC: 11313504.
DOI: 10.3390/ijms25158523.
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.
Bojmar L, Zambirinis C, Hernandez J, Chakraborty J, Shaashua L, Kim J
Nat Med. 2024; 30(8):2170-2180.
PMID: 38942992
PMC: 11416063.
DOI: 10.1038/s41591-024-03075-7.
Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity.
Hsu J, Kim S, Anandasabapathy N
Viruses. 2024; 16(6).
PMID: 38932162
PMC: 11209207.
DOI: 10.3390/v16060870.
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets.
Reschke R, Enk A, Hassel J
Int J Mol Sci. 2024; 25(12).
PMID: 38928238
PMC: 11203481.
DOI: 10.3390/ijms25126532.
T Cell Surveillance during Cutaneous Viral Infections.
Pei L, Hickman H
Viruses. 2024; 16(5).
PMID: 38793562
PMC: 11126121.
DOI: 10.3390/v16050679.
Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis (MASH) Progression.
Maretti-Mira A, Salomon M, Chopra S, Yuan L, Golden-Mason L
Biomedicines. 2024; 12(5).
PMID: 38791066
PMC: 11117983.
DOI: 10.3390/biomedicines12051105.
The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond.
Ngo C, Garrec C, Tomasello E, Dalod M
Cell Mol Immunol. 2024; 21(9):1008-1035.
PMID: 38777879
PMC: 11364676.
DOI: 10.1038/s41423-024-01167-5.
Deciphering the potential role of PGRN in regulating CD8 T cell antitumor immunity.
Zhang W, Qin H, Wang G, Zhang J, He W, Feng C
Cell Death Discov. 2024; 10(1):233.
PMID: 38744851
PMC: 11094002.
DOI: 10.1038/s41420-024-02001-7.
Perspectives on Psoriasiform Adverse Events from Immune Checkpoint Inhibitors: Lessons Learned from Our Practice.
Popa L, Giurcaneanu C, Portelli M, Mihai M, Beiu C, Orzan O
Medicina (Kaunas). 2024; 60(3).
PMID: 38541099
PMC: 10972058.
DOI: 10.3390/medicina60030373.
Correlation analysis between peripheral blood dendritic cell subsets and PD-1 in patients with peritoneal adenocarcinoma.
Hu H, Zhang M
Braz J Med Biol Res. 2024; 57:e13192.
PMID: 38381884
PMC: 10880883.
DOI: 10.1590/1414-431X2023e13192.